Fludarabine and Cyclophosphamide With or Without Rituximab Before CD19 Chimeric Antigen Receptor T Cells for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Condition(s):Recurrent Diffuse Large B-Cell Lymphoma; Refractory Diffuse Large B-Cell LymphomaLast Updated:March 10, 2022Recruiting